- Call 99999 99999
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.
Reference
Source: Primary Care Evaluation of Mental Disorders Patient Health Questionnaire (PRIME-MD-PHQ). The PHQ was developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke, and colleagues. For research information, contact Dr. Spitzer at ris8@columbia.edu PRIME-MD® is a trademark of Pfizer Inc. Copyright© 1999 Pfizer Inc. All rights reserved. Reproduced with permission
Screening Disclaimer
This tool serves a screening purpose and is not a diagnostic measure. Results are intended to support awareness and may be shared with a qualified healthcare or mental health professional. The website and its administrators disclaim responsibility for decisions or outcomes based on the use or interpretation of this screening.
This is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of “not at all,” “several days,” “more than half the days,” and “nearly every day.” GAD-7 total score for the seven items ranges from 0 to 21.
0 – 4
Minimal Anxiety
5 – 9
Mild Anxiety
10 – 14
Moderate Anxiety
15 – 21
Severe Anxiety
Join our monthly newsletter to get helpful mental health tips, new tools, upcoming events, and inspiring stories delivered right to your inbox. Everything is designed to support your wellbeing—one gentle step at a time.
Error: Contact form not found.
Copyright © 2025 SYNAP SCIENCE. All Rights Reserved.